Renal hypomagnesemia 3
MONDO:0009550Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement (FHHN) is a form of familial primary hypomagnesemia (FPH), characterized by recurrent urinary tract infections, nephrolithiasis, bilateral nephrocalcinosis, renal magnesium (Mg) wasting, hypercalciuria and kidney failure.
Also known as: CLDN16 familial primary hypomagnesemia, CLDN16 primary hypomagnesemia, FHHNC without severe ocular involvement, HOMG3, familial primary hypomagnesemia caused by mutation in CLDN16, primary hypomagnesemia caused by mutation in CLDN16, renal hypomagnesemia type 3, hypercalciuria, childhood, self-limiting
3 clinical trials for this condition and its sub-types, 1 tagged with Renal hypomagnesemia 3 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could a diabetes drug protect kidneys in children with genetic disease?
Disease control Recruiting nowThis study tests whether adding dapagliflozin (a diabetes drug) to standard care reduces protein leakage in the urine of children with hereditary kidney diseases. About 44 children will receive either dapagliflozin plus standard care or standard care alone for 12 weeks, then swit…
Phase 3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC